How CREST-2 changes asymptomatic carotid stenosis treatment
Carotid artery disease remains a major contributor to ischemic stroke, one of the leading causes of death and long-term disability in the United States. While symptomatic carotid stenosis has well-established treatment pathways, the management of asymptomatic carotid artery disease remains an area of ongoing debate. Traditional treatment methods such as intensive medical management have largely functioned as the standard of care for asymptomatic carotid artery disease, with revascularization (carotid endarterectomy …
How CREST-2 changes asymptomatic carotid stenosis treatment


















